Category: Life Sciences
Global Life Sciences
-
Peptic Ulcer Testing
... by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Laboratory Tests, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$410.6 Million by ... Read More
-
Monoclonal Antibodies
... at a CAGR of 6.8% over the analysis period 2023-2030. Human-sourced Monoclonal Antibodies, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$105.2 Billion by the end ... Read More
-
The Worldwide Market for Laboratory-Developed Tests (LDTs), 2023-2028
... exploring both the services market and the market for test products sold to clinical laboratories. The Worldwide Market for Laboratory-Developed Tests includes comprehensive analysis of the effects of the FDA's new "Medical Devices: Laboratory Developed ... Read More
-
Infection Surveillance Solutions
... by 2030, growing at a CAGR of 14.2% over the period 2023-2030. Infection Surveillance Software, one of the segments analyzed in the report, is expected to record 13.7% CAGR and reach US$1.2 Billion by the ... Read More
-
Medical Radiation Detection, Monitoring and Safety
... the year 2023, is expected to reach US$1.4 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Personal Dosimeters, one of the segments analyzed in the report, is expected to ... Read More
-
Periodontal Dental Services
... by 2030, growing at a CAGR of 7.5% over the analysis period 2023-2030. Non-Surgical Services, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$17.3 Billion by ... Read More
-
Vascular Grafts
... at a CAGR of 7.5% over the analysis period 2023-2030. Endovascular Aneurysm Repair (EVAR) Indication, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$2.6 Billion by ... Read More
-
Enteral Feeding Pumps
... by 2030, growing at a CAGR of 6.1% over the analysis period 2023-2030. Neurological Disorders Application, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$751.7 Million ... Read More
-
Global Real-Time PCR Reagents and Kits Market Research Report 2024(Status and Outlook)
... reach USD 5623.58 million by 2029, exhibiting a CAGR of 4.00% during the forecast period. This report provides a deep insight into the global Real-Time PCR Reagents and Kits market covering all its essential aspects. ... Read More
-
Global GPCR-targeting Drug Market Research Report 2024(Status and Outlook)
... do this by activating guanine nucleotide-binding proteins (G protein) that are responsible for signal transduction inside the cell. The signal delivery is very important in various cellular responses including cell growth, gene transcription, post-translational changes, ... Read More
-
Online Music Streaming
... by 2030, growing at a CAGR of 15.9% over the analysis period 2023-2030. Audio Streaming, one of the segments analyzed in the report, is expected to record a 14.4% CAGR and reach US$42.7 Billion by ... Read More
-
Collagen and HA-Based Biomaterials
... reach US$13.0 Billion by 2030, growing at a CAGR of 5.8% over the analysis period 2023-2030. Facial Aesthetics Dermal Fillers, one of the segments analyzed in the report, is expected to record a 6.5% CAGR ... Read More
-
Apheresis Equipment
... at a CAGR of 7.9% over the analysis period 2023-2030. Disposable Apheresis Kits, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$3.1 Billion by the end ... Read More
-
Nano-Magnetic Devices
... at a CAGR of 5.5% over the analysis period 2023-2030. Nano-Magnetic Sensors, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$12.8 Billion by the end of ... Read More
-
Trauma Devices
... at a CAGR of 5.4% over the analysis period 2023-2030. Internal Fixators, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$14.9 Billion by the end of ... Read More
-
Spectroscopy Equipment and Accessories
... reach US$19.5 Billion by 2030, growing at a CAGR of 2.8% over the analysis period 2023-2030. Molecular Spectroscopy Equipment, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and ... Read More
-
Breast Biopsy Devices
... by 2030, growing at a CAGR of 5.7% over the analysis period 2023-2030. Biopsy Guidance Systems, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$983.4 Million ... Read More
-
Clinical Diagnostics Automation
... by 2030, growing at a CAGR of 6.6% over the analysis period 2023-2030. The U.S. Market is Estimated at US$1.4 Billion While China is Forecast to Grow at 10.7% CAGR The Clinical Diagnostics Automation market ... Read More
-
Infusion Pumps
... at a CAGR of 4.6% over the analysis period 2023-2030. Volumetric Infusion Pumps, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$2.2 Billion by the end ... Read More
-
Fibromyalgia Therapeutics
... at a CAGR of 3.0% over the analysis period 2023-2030. Antiepileptics Drug Class, one of the segments analyzed in the report, is expected to record a 2.8% CAGR and reach US$2.1 Billion by the end ... Read More
-
Remote Patient Monitoring Systems
... reach US$9.1 Billion by 2030, growing at a CAGR of 19.6% over the analysis period 2023-2030. Special Monitors, one of the segments analyzed in the report, is expected to record a 18.9% CAGR and reach ... Read More
-
Apoptosis
... of 4.6% over the analysis period 2023-2030. Apoptosis Assay Kits, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$3.9 Billion by the end of the analysis ... Read More
-
Melanoma Therapeutics
... at a CAGR of 13.8% over the analysis period 2023-2030. Cutaneous Melanoma Therapeutics, one of the segments analyzed in the report, is expected to record a 13.8% CAGR and reach US$4.3 Billion by the end ... Read More
-
Pediatric Drugs and Vaccines
... reach US$156.7 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2023-2030. Conjugate Technology, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach ... Read More
-
e-Prescription Systems
... at a CAGR of 17.0% over the analysis period 2023-2030. e-Prescription Solutions, one of the segments analyzed in the report, is expected to record a 16.3% CAGR and reach US$3.2 Billion by the end of ... Read More
Research Assistance
